247 related articles for article (PubMed ID: 12520657)
1. Pneumococcal vaccines for infants and children--past, present, and future.
Klein JO
Curr Clin Top Infect Dis; 2002; 22():252-65. PubMed ID: 12520657
[No Abstract] [Full Text] [Related]
2. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].
Rodgers GL; Arguedas A; Cohen R; Dagan R
Vaccine; 2009 Sep; 27(40):5429-30. PubMed ID: 19643215
[No Abstract] [Full Text] [Related]
3. Clinical experience with pneumococcal conjugate vaccines in infants and children.
Jackson CR
J Am Osteopath Assoc; 2002 Aug; 102(8):431-6. PubMed ID: 12201547
[TBL] [Abstract][Full Text] [Related]
4. The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation.
Black S
Pediatr Infect Dis J; 2010 Apr; 29(4):301-3. PubMed ID: 19935444
[No Abstract] [Full Text] [Related]
5. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
[TBL] [Abstract][Full Text] [Related]
6. Immunisation with a pneumococcal 7-valent conjugate vaccine.
Dagan R
Int J Clin Pract; 2002 May; 56(4):287-91. PubMed ID: 12074212
[TBL] [Abstract][Full Text] [Related]
7. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
Reinert RR
Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
[TBL] [Abstract][Full Text] [Related]
8. [Pneumococcal vaccination and serotype replacement: Do we need new vaccination concepts?].
Kenzel S; Hufnagel M; Berner R; Henneke P
Dtsch Med Wochenschr; 2010 Jun; 135(23):1198-200. PubMed ID: 20480453
[No Abstract] [Full Text] [Related]
9. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
Picazo JJ
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
[TBL] [Abstract][Full Text] [Related]
10. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
Dagan R
Vaccine; 2008 Jun; 26 Suppl 2():B16-8. PubMed ID: 18793601
[TBL] [Abstract][Full Text] [Related]
11. Prevention of otitis media: role of pneumococcal conjugate vaccines in reducing incidence and antibiotic resistance.
Jacobs MR
J Pediatr; 2002 Aug; 141(2):287-93. PubMed ID: 12183732
[No Abstract] [Full Text] [Related]
12. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
Prymula R
Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951
[TBL] [Abstract][Full Text] [Related]
13. Prevnar (heptavalent pneumococcal conjugate vaccine): disease prevention in infants and children.
Shields B
J Pediatr Health Care; 2001; 15(4):203-8; quiz 209-10. PubMed ID: 11462129
[No Abstract] [Full Text] [Related]
14. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media.
Jokinen JT; Ahman H; Kilpi TM; Mäkelä PH; Käyhty MH
J Infect Dis; 2004 Aug; 190(3):545-50. PubMed ID: 15243930
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal conjugate vaccines. A review.
Galiza EP; Heath PT
Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
[TBL] [Abstract][Full Text] [Related]
17. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
Sabirov A; Metzger DW
Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
[TBL] [Abstract][Full Text] [Related]
18. Increasing focus on local epidemiology demonstrates potential value of pneumococcal conjugate vaccines in Middle East and North Africa Region.
Pelton SI
Vaccine; 2012 Dec; 30 Suppl 6():G1. PubMed ID: 23228351
[No Abstract] [Full Text] [Related]
19. Comparative in vitro activity of common antibiotics and relationship with changes in Streptococcus pneumoniae serotypes causing otitis in children prior to and 10 years after introduction of conjugate vaccines in Spain.
Fenoll A; Aguilar L; Giménez MJ; Vicioso MD; Robledo O; Granizo JJ; Coronel P
Int J Antimicrob Agents; 2012 Oct; 40(4):376-7. PubMed ID: 22819148
[No Abstract] [Full Text] [Related]
20. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
Rodgers GL; Arguedas A; Cohen R; Dagan R
Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
